Supreme Court Ruling Invalidates Myriad’s BRCA Gene Patents

The Supreme Court announced a unanimous 9-0 decision that genes cannot be patented. After a long legal battle, the high court ruled against Myriad’s patents on two breast cancer susceptibility genes—BRCA1 and BRCA2—declaring that genes are products of nature and cannot be treated as inventions.
Source: Cancer Network - Category: Cancer & Oncology Source Type: news